220.0580; observed: 220.0588.
3-(Methylamino)-1-(4-nitrophenyl)propan-1-ol (4).
To a stirred solution of 3 (500 mg, 2.54 mmol) in dry pyridine (4 mL) was added p-toluenesulfonyl chloride (662 mg, 3.46 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 3 hours and pyridine was removed in vacuo. The resulting residue was dissolved in EtOAc (50 mL), washed with cold aq.
1 N HCl and concentrated aq. NaCl, and dried over anhydrous Na 2 SO 4 . Solvent was removed in vacuo, and the monotosylated product was purified by silica gel chromatography (CHCl 3 /acetone, stepwise gradient from 1:0 to 20:1) to yield 3-hydroxy-3-(4-nitrophenyl)propyl 4-methylbenzenesulfonate as colorless flakes with slight impurities (713 mg, 80% Compound 4 (100 mg, 0.262 mmol) and N,N-diisopropylethylamine (91.0 µL, 0.524 mmol) were dissolved in CH 2 Cl 2 (1.00 mL) and the solution was cooled to 0 °C. Methyladipoyl chloride (40.6 µL, 0.262 mmol) was added over 10 minutes, and the reaction mixture was stirred for 6 hours at room temperature. After the reaction solvent was removed in vacuo, the resulting residue was dissolved in EtOAc, washed twice with saturated aq. NaHCO 3 and then dried over anhydrous Na 2 SO 4 . Solvent was removed in vacuo, and the residue was purified by silica gel chromatography (CHCl 3 /EtOAc, stepwise gradient from 1:0 to 5:1) to yield 5 as a colorless oil (47.9 mg, 52% 2,5-dioxopyrrolidin-1-yl 1-chloro-12-methyl-9-(4-nitrophenyl)-2,7,13-trioxo-8-oxa-3,6,12-triazaoctadecan-18-oate (7). Compound 6 (40.1 mg, 0.0780 mmol) was dissolved in THF (270 µL), and cooled to 0 °C. To this solution, an aqueous solution of LiOH (4.00 mg, 0.0952 mmol in 360 µL water) was added slowly, and allowed to stir at room temperature for 2 hours.
At this time point, the reaction mixture was diluted with EtOAc, washed with 2 M HCl (360 µL), and organic layer was dried over MgSO 4 . Solvent was removed in vacuo to afford crude 1-chloro-12-methyl-9-(4-nitrophenyl)-2,7,13-trioxo-8-oxa-3,6,12-triazaoctadecan-18-oic acid as a colorless oil (34.6 mg, 89% 
Cyclic cMO syntheses
Synthetic procedures identical to those previously reported for a DMNB cyclic ntla cMO 2 were applied to 4-NB cyclic cMOs targeting ntla, pdx1, or mnx1, using bifunctional linker 7 and the 5' amine-and 3'-disulfide-functionalized MOs indicated below. DMNB cMOs targeting pdx1 or mnx1 were similarly prepared with the corresponding DMNB-containing linker. 2 In brief, the 
